Anthony Derek Sung MD
Hematologic Oncology
Medical Instructor, Hematologic Malignancies and Cellular Therapy, Duke University Medical Center
Join to view full profile
2650 Shawnee Mission PkwyWestwood, KS 66205
Phone+1 913-945-6674
Dr. Sung is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
Johns Hopkins UniversityInternship, Internal Medicine, 2008 - 2011
Harvard Medical SchoolClass of 2008
Certifications & Licensure
MO State Medical License 2024 - 2027
KS State Medical License 2024 - 2026
NC State Medical License 2014 - 2025
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
Clinical Trials
- MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
- ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients Start of enrollment: 2020 Oct 14
- Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 Start of enrollment: 2014 Sep 03
Roles: Sub-Investigator, Contact
Publications & Presentations
PubMed
- Early Mortality and Conditional Long-Term Survival After Adult Umbilical Cord Blood Transplantation: A 1-Year Landmark Analysis.Amir Reza Akbari, Matthew L Braun, Nelson J Chao, Mitchell E Horwitz, Anthony D Sung
Transplantation and Cellular Therapy. 2026-08-14 - Adaptive, Stepped-Care for Cancer-Related PTSD Symptoms in HCT Survivors: Results From a SMART Trial.Sophia K Smith, Eric Kuhn, Tamara J Somers, Eric Laber, Cole Manschot
Psycho-Oncology. 2026-08-01 - Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.Allison O Taylor, Joshua S Mercer, Claire I Bradbury, Samantha M Thomas, Edwin Alyea 3rd
Bone Marrow Transplantation. 2026-06-01
Press Mentions
KU-Led Multicenter Trial to Address Food Insecurity and Malnutrition in Cancer PatientsJanuary 13th, 2025- More Options for People with Blood CancersMay 10th, 2023
- FDA Panel Says Poziotinib’s Benefits Don’t Outweigh Risks in NSCLC With HER2 Exon 20 MutationsSeptember 22nd, 2022
Grant Support
- Acceptance and Commitment Therapy to Improve Psychological Resilience and Physical Function in Allogeneic Hematopoietic Stem Cell TransplantationUNIVERSITY OF KANSAS MEDICAL CENTER2026–2031
- Addressing Malnutrition in Transplant and Cellular Therapy Patients with Healthcare-Food Bank PartnershipsUNIVERSITY OF KANSAS MEDICAL CENTER2024–2029
- Home-based Autologous Hematopoietic Stem Cell Transplantation to ImproveOutcomes and Decrease CostsUNIVERSITY OF KANSAS MEDICAL CENTER2020–2026
- Prebiotics to Optimize the Microbiota and Improve Outcomes of AllogeneicHematopoietic Stem Cell TransplantationUNIVERSITY OF KANSAS MEDICAL CENTER2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
